Prefibrotic chronic idiopathic myelofibrosis--a diagnostic enigma?

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Chronic idiopathic myelofibrosis (CIMF) is a myeloproliferative neoplasm characterized by bone marrow fibrosis.
• Understanding precursor lesions is crucial for early diagnosis and improved patient outcomes.

Purpose of the Study:

• To analyze the prodromal bone marrow lesions of chronic idiopathic myelofibrosis (CIMF).
• To evaluate the clinical and histopathological features of prefibrotic CIMF.
• To determine the incidence and survival rates of prefibrotic CIMF compared to overt CIMF.

Main Methods:

• Retrospective analysis of 21 patients with prefibrotic CIMF who later developed overt myelofibrosis.
• Comparison with 211 additional patients at the precursor stage.
• Evaluation of bone marrow histopathology, clinical findings, and survival data.

Main Results:

• Prodromal lesions featured granulocytic and megakaryocytic proliferation with abnormal megakaryocytes.
• Associated findings included borderline anemia, thrombocytosis, and minimal splenomegaly.
• Prefibrotic CIMF had a relative incidence of 24% and a median survival of 143 months, significantly longer than overt CIMF (82 months).

Conclusions:

• Prefibrotic CIMF is characterized by specific bone marrow histopathological and clinical features.
• Early identification of prefibrotic CIMF is associated with a significantly better prognosis.
• Progression to overt myelofibrosis occurs in over 50% of patients, underscoring the need for monitoring.